Filing Flows

Filing Flows › Lifevantage (LFVN) › Q1 2026

Lifevantage (LFVN) Q1 2026 earnings results (first quarter 2026)

10-Q filed May 6, 2026

Lifevantage (LFVN) reported revenue of $43.7M for the first quarter 2026 (Q1 2026), -25% from a year earlier and -11% from the quarter before. Operating margin was 3.8%, net earnings $1.4M (3.1% of revenue).

Revenue$43.7M
Year over year-25%
Quarter over quarter-11%
Operating margin3.8%
Net earnings$1.4M

Lifevantage, Q1 2026: revenue $43.7M (-25% year over year), operating margin 3.8%, net earnings $1.4M, operating cash flow $5.0M. The chart follows the revenue to costs, profit and cash.

Q1 2026AmountQ/QY/Y
Revenue$43.7M-11%-25%
Gross profit$34.5M-5%-27%
Operating profit$1.7M+245%-59%
Net earnings$1.4M+393%-61%
Operating cash flow$5.0M+79%+124%
Free cash flow$4.0M+133%+110%

What changed

Revenue was $43.7M in Q1 2026, down 25% year over year and down 11% from the previous quarter. Protandim was the largest line at 46% of revenue. Life Vantage Product Line lost $10.0M year over year (down 61%), 68% of the total change.

Gross margin was 79.0%, down 2.0 points from Q1 2025. Operating profit was $1.7M, a 3.8% margin (down 3.1 points year over year). Operating expenses fell 24% while revenue fell 25%. Net earnings were $1.4M, down 61% year over year. The effective tax rate was 17.8%.

Operating cash flow was $5.0M (up 124% year over year), 366% of net earnings. Non-cash charges added back $714K of depreciation and amortization and $704K of share-based compensation. Working capital and other items added $2.2M. Capital expenditures of $1.0M left free cash flow of $4.0M.

Questions

What was Lifevantage's revenue in the first quarter 2026?

Lifevantage (LFVN) reported revenue of $43.7M for the first quarter 2026 (Q1 2026), -25% from a year earlier and -11% from the quarter before.

Was Lifevantage profitable in the first quarter 2026?

Operating profit was $1.7M (3.8% of revenue) and net earnings $1.4M.

Open the interactive Sankey →

Source: Lifevantage 10-Q on SEC EDGAR.